Literature DB >> 21949544

Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.

Katia Sutyak Noll1, Patrick J Sinko, Michael L Chikindas.   

Abstract

Subtilosin A is a 35-amino acid long cyclical peptide produced by Bacillus amyloliquefaciens that has potent antimicrobial activity against a variety of human pathogens, including the bacterial vaginosis-related Gardnerella vaginalis. The specific mode of action of subtilosin against G. vaginalis was elucidated by studying its effects on the proton motive force's (PMF) components: transmembrane electric potential (ΔΨ), transmembrane pH gradient (ΔpH), and intracellular ATP levels. The addition of subtilosin to G. vaginalis cells caused an immediate and total depletion of the ΔpH, but had no effect on the ΔΨ. Subtilosin also triggered an instant but partial efflux of intracellular ATP that was twofold higher than that of the positive control bacteriocin, nisin. Taken together, these data suggest that subtilosin inhibits G. vaginalis growth by creating transient pores in the cells' cytoplasmic membrane, leading to an efflux of intracellular ions and ATP and eventually cell death.

Entities:  

Year:  2011        PMID: 21949544      PMCID: PMC3176456          DOI: 10.1007/s12602-010-9061-4

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  40 in total

Review 1.  Bacterial vaginosis: more questions than answers.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

2.  The spectrum of antimicrobial activity of the bacteriocin subtilosin A.

Authors:  Charles E Shelburne; Florence Y An; Vishnu Dholpe; Ayyalusamy Ramamoorthy; Dennis E Lopatin; Marilyn S Lantz
Journal:  J Antimicrob Chemother       Date:  2007-01-09       Impact factor: 5.790

3.  Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa.

Authors:  M M Lubbe; P L Botha; L J Chalkley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

4.  Purification, partial amino acid sequence and mode of action of pediocin PD-1, a bacteriocin produced by Pediococcus damnosus NCFB 1832.

Authors:  R Bauer; M L Chikindas; L M T Dicks
Journal:  Int J Food Microbiol       Date:  2005-05-01       Impact factor: 5.277

5.  Bacterial vaginosis and preterm birth: a prospective community-based cohort study.

Authors:  Pippa Oakeshott; Sally Kerry; Sima Hay; Philip Hay
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

6.  HIV infection and disturbances of vaginal flora during pregnancy.

Authors:  T E Taha; R H Gray; N I Kumwenda; D R Hoover; L A Mtimavalye; G N Liomba; J D Chiphangwi; G A Dallabetta; P G Miotti
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-01-01

7.  Subtilosin production by two Bacillus subtilis subspecies and variance of the sbo-alb cluster.

Authors:  Torsten Stein; Stefanie Düsterhus; Anke Stroh; Karl-Dieter Entian
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

8.  Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis.

Authors:  K Babasaki; T Takao; Y Shimonishi; K Kurahashi
Journal:  J Biochem       Date:  1985-09       Impact factor: 3.387

9.  Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; R P Nugent; D A Eschenbach; M A Krohn; R S Gibbs; D H Martin; M F Cotch; R Edelman; J G Pastorek; A V Rao
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

Review 10.  Maternal infection and adverse fetal and neonatal outcomes.

Authors:  Robert L Goldenberg; Jennifer F Culhane; Derek C Johnson
Journal:  Clin Perinatol       Date:  2005-09       Impact factor: 3.430

View more
  22 in total

1.  Mode of action and safety of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050.

Authors:  S Riazi; S E Dover; M L Chikindas
Journal:  J Appl Microbiol       Date:  2012-07-24       Impact factor: 3.772

2.  Euvesperins A and B, new circumventors of arbekacin resistance in MRSA, produced by Metarhizium sp. FKI-7236.

Authors:  Mayu Shiina; Takuya Suga; Yukihiro Asami; Kenichi Nonaka; Masato Iwatsuki; Satoshi Omura; Kazuro Shiomi
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

3.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 4.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

5.  The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.

Authors:  Veronica L Cavera; Anna Volski; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

6.  Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022.

Authors:  Takuya Suga; Mayu Shiina; Yukihiro Asami; Masato Iwatsuki; Tsuyoshi Yamamoto; Kenichi Nonaka; Rokuro Masuma; Hidehito Matsui; Hideaki Hanaki; Susumu Iwamoto; Hideyuki Onodera; Kazuro Shiomi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2016-06-22       Impact factor: 2.649

7.  Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II.

Authors:  Stephen A Cochrane; Brandon Findlay; Alireza Bakhtiary; Jeella Z Acedo; Eva M Rodriguez-Lopez; Pascal Mercier; John C Vederas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-29       Impact factor: 11.205

Review 8.  Methods to Assess the Antioxidative Properties of Probiotics.

Authors:  P V Zolotukhin; E V Prazdnova; V A Chistyakov
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

Review 9.  Cysteine-rich low molecular weight antimicrobial peptides from Brevibacillus and related genera for biotechnological applications.

Authors:  Piyush Baindara; Anoop Kapoor; Suresh Korpole; Vishakha Grover
Journal:  World J Microbiol Biotechnol       Date:  2017-05-22       Impact factor: 3.312

10.  Bacteriostatic Mode of Action of Trypsin-Hydrolyzed Palm Kernel Expeller Peptide Against Bacillus cereus.

Authors:  Yen Nee Tan; Karl R Matthews; Rong Di; Mohd Khan Ayob
Journal:  Probiotics Antimicrob Proteins       Date:  2012-03       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.